Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
RXRX
RXRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest RXRX ETF News Today | Earnings, Events & Price Alerts
RXRX News
Recursion Pharmaceuticals Q4 2025 Earnings Call Insights
5d ago
seekingalpha
Recursion Pharmaceuticals Q4 Earnings Exceed Expectations
5d ago
seekingalpha
Recursion Pharmaceuticals Stock Surges After Strong Earnings Report
5d ago
Benzinga
Totaligent Forms Joint Venture with GloMed for Biologics Distribution
5d ago
Newsfilter
Recursion Pharmaceuticals Q4 2025 Earnings Highlights
6d ago
seekingalpha
Recursion Pharmaceuticals Q4 Results Exceed Expectations, Shares Surge
6d ago
stocktwits
Recursion Achieves Clinical Validation of AI Operating System
6d ago
Newsfilter
ARK Invest's 2025 Performance Review Highlights Key Stocks
6d ago
Benzinga
Recursion Pharmaceuticals Set to Announce Q4 Earnings on February 25
6d ago
seekingalpha
Earnings Reports Week for Major Companies
Feb 23 2026
Benzinga
Analysis of Three Declining Growth Stocks
Feb 22 2026
Fool
ARK Invest Increases Figma Stake and Reduces DraftKings Holdings
Feb 20 2026
Yahoo Finance
Nvidia Sold Its Shares, Cathie Wood Invested. A Pharmaceutical Stock is Dividing Investors.
Feb 19 2026
Barron's
Recursion Pharmaceuticals Shares Under Pressure as Nvidia Exits Investment
Feb 18 2026
Benzinga
Palo Alto's Q2 Earnings Beat Estimates but Guidance Lowered
Feb 18 2026
Benzinga
Recursion Schedules Q4 and Full Year 2025 Earnings Call
Feb 18 2026
Newsfilter
Show More News
